Medpace (NASDAQ: MEDP)
Medpace Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Medpace Company Info
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
News & Analysis
Better Healthcare Buy for 2023: Medpace Holdings or Doximity?
The healthcare stocks expect similar revenue growth in 2023.
Why Medpace Holdings Jumped 41.5% This Week
The clinical contract research organization is seeing an increase in new business.
Why Medpace Stock Soared Today
The clinical trial specialist is winning new business at an impressive clip.
This Diversified Healthcare Stock Offers Explosive Biotech-Like Growth
Since its IPO five years ago, this clinical trial specialist is up over 700%.
Why Medpace Holdings Is Skyrocketing 13.5% Higher Today
The clinical trial company's second-quarter financial results were better than expected.
Will COVID-19 Derail New Drugs?
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
These Were the 10 Best Healthcare Stocks of 2019
Helping people stricken with illness can be richly rewarding in more ways than one.
4 Healthcare Services Companies to Own for the Future
Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.